Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal (CRE NIS)

AstraZeneca

Status: Completed

Conditions: Hyperlipidemia

Study type: Observational

Funder types: Industry

Identifiers

NCT00781560

NIS-CCN-CRE-2008/1

Details and patient eligibility

About

This study is designed to survey the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists; To survey the control rate of the patients with dyslipidemia in "real world"; and to evaluate the percentage of hyperlipidemia patients who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) following 8-week treatment by Crestor® 5mg or 10mg

Enrollment: 2,575 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed as dyslipidemia by doctors
• Having lipids test and record within one months
• Diagnosed as hypercholesterolemia or mixed dyslipidaemias and has been prescribed Crestor® 5mg or 10mg

Exclusion criteria

• Unable or unwilling to provide the Inform Consent

Trial design

2,575 participants in 2 patient groups

1

Description:

patients being diagnosed as dyslipidemia but not receiving Crestor®

2

Description:

hypercholesterolemia or mixed dyslipidemia and have been initiated treatment with Crestor®